Brimonidine Tartrate
Who holds supplier records for Brimonidine Tartrate? 12 organisations hold a current record for Brimonidine Tartrate: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 11 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (8), Spain (1) and United States (1); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Brimonidine Tartrate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/brimonidine-tartrate
Reading the evidence
- 12 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
8 of the 10 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 10 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (12)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Brimonidine Tartrate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- CENTAUR PHARMACEUTICALS PVT LTDIndiaCEP Company GMP cert on recordActive DMF 23880 · latest filing Jun 2010
- CZECH-GEN ASCEP Company GMP cert on recordActive DMF 15585 · latest filing Aug 2001
- INDOCO REMEDIES LTDIndiaCEP Company GMP cert on recordActive DMF 22166 · latest filing Oct 2008
- MAITHRI DRUGS PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 36595 · latest filing Dec 2021
- MEDICHEM SASpainCEP Company GMP cert on recordActive DMF 15601 · latest filing Aug 2001
- MICRO LABS LTDIndiaCEP Company GMP cert on recordActive DMF 34362 · latest filing Dec 2019
- Piramal Pharma LimitedIndiaCEP Company GMP cert on recordActive DMF 17588 · latest filing Aug 2004
- SIEGFRIED GRAFTON INCCEPActive DMF 24213 · latest filing Sept 2010
- Viyash Scientific LtdIndiaCEP Company GMP cert on recordActive DMF 22230 · latest filing Dec 2008
- C-SQUARED PHARMA LTDUnited StatesCEPActive DMF 22510 · latest filing Jan 2009
- FDC LimitedIndiaCEP Company GMP cert on recordActive DMF 20855 · latest filing Sept 2007
- Unichem Laboratories Ltd.India Company GMP cert on recordActive DMF 25051 · latest filing Jul 2011
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (11)
Certificates of Suitability on the EDQM register for Brimonidine Tartrate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| CZECH-GEN A.S. Olomouc | CZ | CEP 2014-331 - Rev 05 Brimonidine tartrate | Jul 2026 | Inspected Sept 2024 Czechia |
| VIYASH SCIENTIFIC LIMITED Hyderabad | IN | CEP 2018-124 - Rev 03 Brimonidine tartrate | Jul 2026 | — |
| FDC LIMITED Mumbai | IN | CEP 2020-123 - Rev 02 Brimonidine tartrate | May 2026 | — |
| SIEGFRIED GRAFTON, INC. Grafton | US | CEP 2015-265 - Rev 01 Brimonidine tartrate | Aug 2025 | — |
| MICRO LABS LIMITED Bengaluru | IN | CEP 2019-335 - Rev 03 Brimonidine tartrate | Jun 2025 | — |
| CENTAUR PHARMACEUTICALS PRIVATE LIMITED Mumbai | IN | CEP 2022-451 - Rev 00 Brimonidine tartrate | Nov 2024 | — |
| INDOCO REMEDIES LIMITED Mumbai | IN | CEP 2014-180 - Rev 01 Brimonidine tartrate | Mar 2024 | — |
| C-SQUARED PHARMA LIMITED Cork | IE | CEP 2022-161 - Rev 00 Brimonidine tartrate | Feb 2024 | — |
| MAITHRI DRUGS PRIVATE LIMITED Bonthapally Village | IN | R0-CEP 2021-507 - Rev 00 Brimonidine tartrate | Jul 2023 | — |
| PIRAMAL PHARMA LIMITED Digwal Village | IN | R1-CEP 2015-052 - Rev 01 Brimonidine tartrate | Jan 2022 | — |
| Medichem, S.A. Sant Joan Despí | ES | R1-CEP 2013-353 - Rev 00 Brimonidine tartrate | Apr 2019 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (1)
Organisations whose Type II DMFs for Brimonidine Tartrate are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- India · Inactive DMF 25259 · filed Oct 2011
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Brimonidine Tartrate is an alpha-2 adrenergic receptor agonist primarily used to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It works by decreasing the production of aqueous humor and increasing uveoscleral outflow.
Chemical identity
- IUPAC name
- 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine;(2R,3R)-2,3-dihydroxybutanedioic acid
- Canonical SMILES
- C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
- InChIKey
- QZHBYNSSDLTCRG-LREBCSMRSA-N
- Synonyms
- Mirvaso API, agn 190342-lf, agn-190342-lf, agn-190342lf, alphagan, brimonidine d-tartrate, bromoxidine tartrate, cd-07805, cd-07805/47, cd07805/47, combigan component brimonidine tartrate, lumify
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- alpha-Adrenergic Agonist
- Mechanism of action
- Adrenergic alpha-Agonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Brimonidine Tartrate?
12 organisations hold an active US FDA Type II Drug Master File or a CEP for Brimonidine Tartrate: CENTAUR PHARMACEUTICALS PVT LTD (India), CZECH-GEN AS, INDOCO REMEDIES LTD (India), MAITHRI DRUGS PRIVATE LTD (India), MEDICHEM SA (Spain), MICRO LABS LTD (India), Piramal Pharma Limited (India) and SIEGFRIED GRAFTON INC, and 4 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Brimonidine Tartrate Drug Master Files are active?
CENTAUR PHARMACEUTICALS PVT LTD (DMF 23880), CZECH-GEN AS (DMF 15585), INDOCO REMEDIES LTD (DMF 22166), MAITHRI DRUGS PRIVATE LTD (DMF 36595), MEDICHEM SA (DMF 15601), MICRO LABS LTD (DMF 34362), Piramal Pharma Limited (DMF 17588) and SIEGFRIED GRAFTON INC (DMF 24213) and 4 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Brimonidine Tartrate records mean?
1 organisation has only inactive Type II DMFs for Brimonidine Tartrate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Brimonidine Tartrate have a European Certificate of Suitability?
Yes. 11 organisations hold a valid CEP for Brimonidine Tartrate on the EDQM register, including CZECH-GEN A.S. Olomouc (CZ), VIYASH SCIENTIFIC LIMITED Hyderabad (IN), FDC LIMITED Mumbai (IN), SIEGFRIED GRAFTON, INC. Grafton (US), MICRO LABS LIMITED Bengaluru (IN) and CENTAUR PHARMACEUTICALS PRIVATE LIMITED Mumbai (IN) and 5 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Brimonidine Tartrate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Brimonidine Tartrate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.